Loading…

Principal Component Analysis, Hierarchical Clustering, and Decision Tree Assessment of Plasma mRNA and Hormone Levels as an Early Detection Strategy for Small Intestinal Neuroendocrine (Carcinoid) Tumors

Incidence of neuroendocrine tumors (NETs) is increasing (approximately 6%/year), but clinical presentation is nonspecific, resulting in delays in diagnosis (5–7 years; approximately 70% have metastases). This reflects absence of a sensitive plasma marker. The aim of this study is to investigate whet...

Full description

Saved in:
Bibliographic Details
Published in:Annals of surgical oncology 2009-02, Vol.16 (2), p.487-498
Main Authors: Modlin, Irvin M., Gustafsson, Björn I., Drozdov, Ignat, Nadler, Boaz, Pfragner, Roswitha, Kidd, Mark
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Incidence of neuroendocrine tumors (NETs) is increasing (approximately 6%/year), but clinical presentation is nonspecific, resulting in delays in diagnosis (5–7 years; approximately 70% have metastases). This reflects absence of a sensitive plasma marker. The aim of this study is to investigate whether detection of circulating messenger RNA (mRNA) alone or in combination with circulating NET-related hormones and growth factors can detect gastrointestinal NET disease. The small intestinal (SI) NET cell line KRJ-I was used to define the sensitivity of real-time polymerase chain reaction (PCR) for mRNA detection in blood. NSE , Tph-1 , and VMAT 2 transcripts were identified from one KRJ-I cell/ml blood. mRNA from the tissue and plasma of SI-NETs ( n  = 12) and gastric NETs ( n  = 7), and plasma from healthy controls ( n  = 9) was isolated and real-time PCR performed. Tph-1 was a specific marker of SI-NETs (58%, p  
ISSN:1068-9265
1534-4681
DOI:10.1245/s10434-008-0251-1